(Total Views: 471)
Posted On: 08/12/2019 11:31:13 AM
Post# of 36568
https://storage.googleapis.com/wzukusers/user...6_2019.pdf
Generex Biotechnology Corporation(www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased toannounce that the company will dividend Generex shareholders with shares in our wholly-owned subsidiary NuGenerex Immuno-Oncology (formerly Antigen Express), with the ultimate plan to spin out the company on a public exchange.
NGIO is still a wholly owned subsidiary of Generex. For now the share are privately owned and cannot be traded until they are spun out on to a public exchange. I could be wrong, but the most likely public exchange is NASDAQ.
Generex Biotechnology Corporation(www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) is pleased toannounce that the company will dividend Generex shareholders with shares in our wholly-owned subsidiary NuGenerex Immuno-Oncology (formerly Antigen Express), with the ultimate plan to spin out the company on a public exchange.
NGIO is still a wholly owned subsidiary of Generex. For now the share are privately owned and cannot be traded until they are spun out on to a public exchange. I could be wrong, but the most likely public exchange is NASDAQ.
(1)
(0)
